Men with localised prostate cancer could benefit from a shorter course of radiotherapy, after new research data shows that just two higher-dose treatments are as safe as a standard five-session ...

If you’re a man over 50 reading this with a cup of coffee in one hand, there’s a fair chance you’ve already been up to the ...

MINNEAPOLIS, May 6, 2026 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company based in Maple Grove, Minn., today announced that Naveen Kella, MD, of The Urology Place has ...

Among men with high-risk localized prostate cancer, those receiving neoadjuvant apalutamide combination therapy had improved potency recovery by 12 months and reduced rates of positive margins ...

At the 2024 ESMO Congress, an expert explained how Nubeqa may reduce fatigue-related side effects in metastatic hormone-sensitive prostate cancer. Newer treatments for metastatic hormone-sensitive ...

A groundbreaking new study suggests that prostate cancer treatment may soon become faster, simpler, and less disruptive for ...

Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five doses of radiotherapy, according to results presented at the Congress of the ...

Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, ...

Although men have several different options to enhance their manhood, a new offering by a New Jersey-based urologist claims ...

By Nancy Lapid May 6 (Reuters) - An experimental drug from Revolution Medicines that nearly doubled survival time for patients with advanced pancreas cancer in clinical trials comes with a high rate ...

Lupron Depot (leuprolide acetate) is a brand-name injection prescribed for prostate cancer and other hormone-related conditions. Lupron Depot’s side effects may vary depending on the dosage and the ...